Phase II Clinical, Biological and Pharmacological Study of Rapamycin (Rapamune, Sirolimus) in Patients With Advanced Pancreatic Cancer.
Phase of Trial: Phase II
Latest Information Update: 23 May 2018
At a glance
- Drugs Sirolimus (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 06 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Feb 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.